期刊文献+

系统性红斑狼疮相关新型药物及治疗方式的研究进展 被引量:4

下载PDF
导出
摘要 当前关于系统性红斑狼疮疾病的治疗方式多种多样,疗效也是各有优劣,寻求疗效最好,毒性最小,不良反应最少的治疗方式一直是研究者的目的。当今系统性红斑狼疮的治疗主要以免疫抑制剂和激素为主。随着各个学科的不断发展和相关研究的不断深入,新型免疫抑制剂、生物制剂和干细胞移植等被更多地用于治疗,疗效也相当显著。其中,不仅对沙利度胺、他克莫斯等新型药物的治疗效果进行了一定的分析,甚至对系统性红斑狼疮易感基因进行定位分析,以期能从基因层面进行治疗,这将可能为系统性红斑狼疮的治愈带来希望。对系统性红斑狼疮治疗药物和治疗方式研究进展的阐述,对临床治疗具有一定指导意义。
出处 《医学研究杂志》 2016年第8期168-172,共5页 Journal of Medical Research
  • 相关文献

参考文献25

  • 1Kelly JA, Thompson K, Kilpatrick J, et al. Evidence for a suscepti- bility gene ( SLEH1 ) on chromosome 11q14 for systemic lupus erythe- matosus (SLE) families with hemolytic anemia [ J ]. Proc Natl Acad Sci U S A, 2002, 99(18) : 11766 -11771.
  • 2Gaffney PM, Kearns GM, Shark KB, et al. A genome - wide search for susceptibility genes in human systemic lupus erythematosus sib -pair families [J]. Proe Natl Acad Sci U S A, 1998, 95(25) : 14875 - 14879.
  • 3Chamaillard M, Philpott D, Girardin SE, et al. Gene - environment interaction modulated by allelic heterogeneity in inflammatory diseases [J]. Proc NatlAcadSciU SA, 2003, 100(6): 3455 -3460.
  • 4Graham RR, Ortmann WA, Langefeld CD, et al. Visualizing human leukocyte antigen class II risk haplntypes in human systemic lupus ery- thematosus [ J]. Am J Hum Genet 2002, 71 (3) : 543 - 553.
  • 5Mitchell DA, Pickering MC, Warren J, et al. Clq deficiency and au- toimmunity: the effects of genetic background on disease expression [J]. JImmunol, 2002, 168(5): 2538 -2543.
  • 6Liu JL, Zhang FY, Liang YH, et al. Association between the PD1. 3A/G polymorpbism of tbePDCD1 gene and systemic lupus erythemato- sus in European populations : a Meta - analysis [ J]. J Eur Acad Der- matol Venereol, 2009, 23 (4) : 425 -432.
  • 7Davis JC, Austin H, Boumpas D, et al. A pilot study of 2 -chloro - 2' - deoxyadenosine in the treatment of systemic lupus erythematosus - associated glomerulonephritis [ J ]. Arthritis Rheum, 1998, 41 (2) : 335 -343.
  • 8Choi D, Kim BH, Lee MK, et al. Effects of water - soluble tacroli- mus- PEG conjugate on insulin - dependent diabetes mellitus and systemic lupus erythcmatosus [ J]. Arch Pharm Res, 2011, 34 ( 8 ) : 1301 - 1310.
  • 9Housman TS, Jorizzo JL, McCarty MA, et al. Low - dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus [ J]. Arch Dermatol, 2003, 139(1): 50-54.
  • 10Cortes - Hernandez J, Torres - Salido M, Castro - Marrero J, et al. Thalidomide in the treatment of refractory cutaneous lupus erytbemato- sus: prognostic factors of clinical outcome [ J]. Br J Dermatol, 2012, 166(3) : 616 -623.

同被引文献53

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部